Cancer cells undergoing immunogenic cell death (ICD) can initiate adaptive immune
responses against dead cell‐associated antigens, provided that (1) said antigens are not …

Myeloproliferative neoplasms research has entered a dynamic and exciting era as we
witness exponential growth of novel agents in advanced/early phase clinical trials for …

Myeloproliferative Neoplasms (MPNs) constitute a group of rare blood cancers that are
characterized by mutations in bone marrow stem cells leading to the overproduction of …

Essential thrombocythemia (ET) is a blood cancer. ET is characterized by an overproduction
of platelets that can lead to thrombosis formation. Platelet overproduction occurs in …

Purpose of the study Calreticulin is an endoplasmic reticulum chaperone protein, which is
involved in protein folding and in peptide loading of major histocompatibility complex class I …

Background Essential thrombocythemia (ET), polycythemia vera (PV), and primary
myelofibrosis (MF) are myeloproliferative neoplasms (MPN). Inflammation is involved in the …

It is now clear that radiation therapy (RT) can be delivered in doses and according to
fractionation schedules that actively elicit immunostimulatory effects. While such effects are …